Ulcerative colitis associated with vitiligo and IgA deficiency in a young girl

Irina Naumcieff, Marin Burlea, Smaranda Diaconescu, Mădălina Ionela Chiriac, Claudia Olaru, Nicoleta Gimiga, Gabriela Ciubotariu, Doina Mihăilă, Gabriela Ștefănescu, Laura Mihaela Trandafir

Abstract


Ulcerative colitis (UC) is a chronic inflammatory disease of non-infectious and plurifactorial etiology, exclusively affecting the colon, with variable expansion. The selective deficiency of immunoglobulin A (IgA) can be frequently associated with UC, as well as with recurrent respiratory tract infections, autoimmune diseases, atopy. The incidence of vitiligo among UC patients is significantly higher compared to the general population. At the same time, recent studies proved a higher incidence of Clostridium difficile infections in patients with inflammatory bowel disease (Crohn’s disease and ulcerative colitis) compared to the general population. We are presenting the case of a 9 year old girl, where UC associated with selective deficiency of IgA and vitiligo hampered the diagnosis and therapeutic approach, particularly in the conditions of a preexisting Clostridium difficile infection. The association of these entities is rare in the pediatric population and a multidisciplinary team approach (gastroenterology, dermatology and immunology) can ensure an effective therapeutic management in the case of such patients.


Keywords


reversal ulcerative colitis, child, IgA deficiency, vitiligo

Full Text:

PDF

References


IBD working group of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis – the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41:1-7.

Levine A, Koletzko S, Turner D, et al. IBD working group of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis – the Porto criteria. J Pediatr Gastroenterol Nutr 2014; 58:795–806.

Pascarella F, Martinelli M, Miele E, Del Pezzo M, Roscetto E, Staiano A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009; 154(6):854–856.

Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008; 57(2):205–210.

Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract 2011; Article ID 136064.

Turner D, Levine A, Escher J, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012; 55(3):340–361.

Yel L. Selective IgA Deficiency. J Clin Immunol 2010; 30(1):10–16.

Ludvigsson JF. Association between IgA deficiency and other autoimmune conditions: a population-based matched cohort study. J Clin Immunol 2014; 34(4):444-451.

Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol 2012; 3:13.

Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol. Hepatol. 2011; 7(4):235–241.

Quan C, Ren YQ, Xiang LH, et al. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 2010; 42: 614–618.

Pashankar D, Prendiville J, Israel DM. Vitiligo and Crohn’s disease in children. J Pediatr Gastroenterol Nutr 1999; 28:227–229.

http://www.rccc.ro/uploads/media/default/0001/01/964c90b3de152e07024e51844f96b185783adf3a.pdf. [available at 03/29/2017]

Derikx LA, Dieleman LA, Hoentjen F. Probiotics and prebiotics in ulcerative colitis. Best Pract Res Clin Gastroenterol 2016; 30(1):55-71.

Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle1917 is as effective as with standard mesalazine. Gut 2004; 53:1617-1623.

Miele E, Pascarella F, Ginnetti E, Staiano A. Effect of probiotic preparation (VSL13) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104:437-443.

Kunde S, Pham A, Bonczyk S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56(6):597–601.




DOI: http://dx.doi.org/10.22551/2017.14.0401.10092

Copyright (c) 2017 Irina Naumcieff, Marin Burlea, Smaranda Diaconescu, Mădălina Ionela Chiriac, Claudia Olaru, Nicoleta Gimiga, Gabriela Ciubotariu, Doina Mihăilă, Gabriela Ștefănescu, Laura Mihaela Trandafir

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

ISSN: 2360-6975